Trial Outcomes & Findings for Titrated Disease Management for Patients With Hypertension (NCT NCT01390272)

NCT ID: NCT01390272

Last Updated: 2019-02-11

Results Overview

Continuous change in systolic blood pressure was measured as the primary outcome. Mean systolic blood pressure was calculated by the average of 3 blood pressure measurements collected at the 6- month study visits.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

385 participants

Primary outcome timeframe

6 months

Results posted on

2019-02-11

Participant Flow

The study was conducted among patients receiving primary care at the Durham VAMC, including VA Community Based Outpatient Clinics (CBOC).

Participant milestones

Participant milestones
Measure
Titration Intervention
The intervention arm includes three levels of resource intensity targeted to improve patients' systolic blood pressure (SBP) \[top number of blood pressure measurement\]. Medium/level 1 resource intensity: a registered nurse (RN) will provide monthly tailored behavioral support telephone calls + home BP monitoring. High/level 2 resource intensity: a pharmacist will provide monthly tailored behavioral support telephone calls + home BP monitoring + pharmacist-directed medication management. Booster (low) resource intensity: a licensed practical nurse (LPN) will provide non-tailored behavioral support telephone calls every two months to patients whose SBP comes under control. Booster/ low resource: A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months.
LPN Control
A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months (identical to booster (low) resource intensity component of the titrated intervention). The control arm will utilize the same procedures as the booster level for intervention patients for whom SBP comes under control. Booster/ low resource: A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months.
Overall Study
STARTED
192
193
Overall Study
6 Month Follow up
162
171
Overall Study
12 Month Follow up
139
159
Overall Study
18 Month Follow up
155
160
Overall Study
COMPLETED
175
178
Overall Study
NOT COMPLETED
17
15

Reasons for withdrawal

Reasons for withdrawal
Measure
Titration Intervention
The intervention arm includes three levels of resource intensity targeted to improve patients' systolic blood pressure (SBP) \[top number of blood pressure measurement\]. Medium/level 1 resource intensity: a registered nurse (RN) will provide monthly tailored behavioral support telephone calls + home BP monitoring. High/level 2 resource intensity: a pharmacist will provide monthly tailored behavioral support telephone calls + home BP monitoring + pharmacist-directed medication management. Booster (low) resource intensity: a licensed practical nurse (LPN) will provide non-tailored behavioral support telephone calls every two months to patients whose SBP comes under control. Booster/ low resource: A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months.
LPN Control
A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months (identical to booster (low) resource intensity component of the titrated intervention). The control arm will utilize the same procedures as the booster level for intervention patients for whom SBP comes under control. Booster/ low resource: A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months.
Overall Study
Death
3
2
Overall Study
Withdrawal by Subject
9
5
Overall Study
Patient moved, no longer eligible
5
8

Baseline Characteristics

Titrated Disease Management for Patients With Hypertension

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Titration Intervention
n=192 Participants
The intervention arm includes three levels of resource intensity targeted to improve patients' systolic blood pressure (SBP) \[top number of blood pressure measurement\]. Medium/level 1 resource intensity: a registered nurse (RN) will provide monthly tailored behavioral support telephone calls + home BP monitoring. High/level 2 resource intensity: a pharmacist will provide monthly tailored behavioral support telephone calls + home BP monitoring + pharmacist-directed medication management. Booster (low) resource intensity: a licensed practical nurse (LPN) will provide non-tailored behavioral support telephone calls every two months to patients whose SBP comes under control. Booster/ low resource: A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months.
LPN Control
n=193 Participants
A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months (identical to booster (low) resource intensity component of the titrated intervention). The control arm will utilize the same procedures as the booster level for intervention patients for whom SBP comes under control. Booster/ low resource: A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months.
Total
n=385 Participants
Total of all reporting groups
Age, Continuous
64.2 years
STANDARD_DEVIATION 9.0 • n=93 Participants
62.9 years
STANDARD_DEVIATION 8.5 • n=4 Participants
63.5 years
STANDARD_DEVIATION 8.8 • n=27 Participants
Sex: Female, Male
Female
16 Participants
n=93 Participants
13 Participants
n=4 Participants
29 Participants
n=27 Participants
Sex: Female, Male
Male
176 Participants
n=93 Participants
180 Participants
n=4 Participants
356 Participants
n=27 Participants

PRIMARY outcome

Timeframe: Baseline

Continuous change in systolic blood pressure was measured as the primary outcome. Mean systolic blood pressure was calculated by the average of 3 blood pressure measurements collected at the baseline study visits.

Outcome measures

Outcome measures
Measure
Titration Intervention
n=192 Participants
The intervention arm includes three levels of resource intensity targeted to improve patients' systolic blood pressure (SBP) \[top number of blood pressure measurement\]. Medium/level 1 resource intensity: a registered nurse (RN) will provide monthly tailored behavioral support telephone calls + home BP monitoring. High/level 2 resource intensity: a pharmacist will provide monthly tailored behavioral support telephone calls + home BP monitoring + pharmacist-directed medication management. Booster (low) resource intensity: a licensed practical nurse (LPN) will provide non-tailored behavioral support telephone calls every two months to patients whose SBP comes under control. Booster/ low resource: A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months.
LPN Control
n=193 Participants
A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months (identical to booster (low) resource intensity component of the titrated intervention). The control arm will utilize the same procedures as the booster level for intervention patients for whom SBP comes under control. Booster/ low resource: A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months.
Systolic Blood Pressure
143.5 mmHg
Standard Deviation 17.7
143.7 mmHg
Standard Deviation 17.5

PRIMARY outcome

Timeframe: 6 months

Population: 30 out of the 192 participants in the Titration Intervention group and 22 out of the 193 in the LPN control group had missing blood pressure measurement at 6 months due to not completing the assessment. One additional participant in the LPN control had missing blood pressure measurement at 6 months due to not being able to get a reading.

Continuous change in systolic blood pressure was measured as the primary outcome. Mean systolic blood pressure was calculated by the average of 3 blood pressure measurements collected at the 6- month study visits.

Outcome measures

Outcome measures
Measure
Titration Intervention
n=162 Participants
The intervention arm includes three levels of resource intensity targeted to improve patients' systolic blood pressure (SBP) \[top number of blood pressure measurement\]. Medium/level 1 resource intensity: a registered nurse (RN) will provide monthly tailored behavioral support telephone calls + home BP monitoring. High/level 2 resource intensity: a pharmacist will provide monthly tailored behavioral support telephone calls + home BP monitoring + pharmacist-directed medication management. Booster (low) resource intensity: a licensed practical nurse (LPN) will provide non-tailored behavioral support telephone calls every two months to patients whose SBP comes under control. Booster/ low resource: A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months.
LPN Control
n=171 Participants
A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months (identical to booster (low) resource intensity component of the titrated intervention). The control arm will utilize the same procedures as the booster level for intervention patients for whom SBP comes under control. Booster/ low resource: A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months.
Systolic Blood Pressure
137.1 mmHg
Standard Deviation 17.7
140.3 mmHg
Standard Deviation 18.0

PRIMARY outcome

Timeframe: 12 months

Population: Analysis Population Description: Analysis Population Description: 53 out of the 192 participants in the Titration Intervention group and 34 out of the 193 in the LPN control group had missing blood pressure measurement at 12 months due to not completing the assessment.

Continuous change in systolic blood pressure was measured as the primary outcome. Mean systolic blood pressure was calculated by the average of 3 blood pressure measurements collected at the12-month study visits.

Outcome measures

Outcome measures
Measure
Titration Intervention
n=139 Participants
The intervention arm includes three levels of resource intensity targeted to improve patients' systolic blood pressure (SBP) \[top number of blood pressure measurement\]. Medium/level 1 resource intensity: a registered nurse (RN) will provide monthly tailored behavioral support telephone calls + home BP monitoring. High/level 2 resource intensity: a pharmacist will provide monthly tailored behavioral support telephone calls + home BP monitoring + pharmacist-directed medication management. Booster (low) resource intensity: a licensed practical nurse (LPN) will provide non-tailored behavioral support telephone calls every two months to patients whose SBP comes under control. Booster/ low resource: A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months.
LPN Control
n=159 Participants
A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months (identical to booster (low) resource intensity component of the titrated intervention). The control arm will utilize the same procedures as the booster level for intervention patients for whom SBP comes under control. Booster/ low resource: A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months.
Systolic Blood Pressure
135.9 mmHg
Standard Deviation 15.7
138.4 mmHg
Standard Deviation 17.5

PRIMARY outcome

Timeframe: 18 months

Population: 37 out of the 192 participants in the Titration Intervention group and 33 out of the 193 in the LPN control group had missing blood pressure measurement at 18 months due to not completing the assessment.

Continuous change in systolic blood pressure was measured as the primary outcome. Mean systolic blood pressure was calculated by the average of 3 blood pressure measurements collected at the18- month study visits.

Outcome measures

Outcome measures
Measure
Titration Intervention
n=155 Participants
The intervention arm includes three levels of resource intensity targeted to improve patients' systolic blood pressure (SBP) \[top number of blood pressure measurement\]. Medium/level 1 resource intensity: a registered nurse (RN) will provide monthly tailored behavioral support telephone calls + home BP monitoring. High/level 2 resource intensity: a pharmacist will provide monthly tailored behavioral support telephone calls + home BP monitoring + pharmacist-directed medication management. Booster (low) resource intensity: a licensed practical nurse (LPN) will provide non-tailored behavioral support telephone calls every two months to patients whose SBP comes under control. Booster/ low resource: A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months.
LPN Control
n=160 Participants
A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months (identical to booster (low) resource intensity component of the titrated intervention). The control arm will utilize the same procedures as the booster level for intervention patients for whom SBP comes under control. Booster/ low resource: A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months.
Systolic Blood Pressure
136.1 mmHg
Standard Deviation 17.6
138.0 mmHg
Standard Deviation 18.5

SECONDARY outcome

Timeframe: Baseline

Population: Mean systolic blood pressure in control (units: participants)

The investigators examined the difference in the degree of systolic BP control over the 18 months of the study between the intervention and control arms. Control was defined as SBP \< 130mmHg for hypertensive patients with diabetes and \< 140mmHg for patients without diabetes. Mean systolic blood pressure was calculated by the average of 3 blood pressure measurements collected at the baseline study visit.

Outcome measures

Outcome measures
Measure
Titration Intervention
n=192 Participants
The intervention arm includes three levels of resource intensity targeted to improve patients' systolic blood pressure (SBP) \[top number of blood pressure measurement\]. Medium/level 1 resource intensity: a registered nurse (RN) will provide monthly tailored behavioral support telephone calls + home BP monitoring. High/level 2 resource intensity: a pharmacist will provide monthly tailored behavioral support telephone calls + home BP monitoring + pharmacist-directed medication management. Booster (low) resource intensity: a licensed practical nurse (LPN) will provide non-tailored behavioral support telephone calls every two months to patients whose SBP comes under control. Booster/ low resource: A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months.
LPN Control
n=193 Participants
A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months (identical to booster (low) resource intensity component of the titrated intervention). The control arm will utilize the same procedures as the booster level for intervention patients for whom SBP comes under control. Booster/ low resource: A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months.
Number of Participants With Hypertension Control
47 Participants
43 Participants

SECONDARY outcome

Timeframe: 6 months

Population: 30 out of the 192 participants in the Titration Intervention group and 22 out of the 193 in the LPN control group had missing blood pressure measurement at 6 months due to not completing the assessment. One additional participant in the LPN control had missing blood pressure measurement at 6 months due to not being able to get a reading.

The investigators examined the difference in the degree of systolic BP control over the 18 months of the study between the intervention and control arms. Control was defined as SBP \< 130mmHg for hypertensive patients with diabetes and \< 140mmHg for patients without diabetes. Mean systolic blood pressure was calculated by the average of 3 blood pressure measurements collected at the 6-month study visit.

Outcome measures

Outcome measures
Measure
Titration Intervention
n=162 Participants
The intervention arm includes three levels of resource intensity targeted to improve patients' systolic blood pressure (SBP) \[top number of blood pressure measurement\]. Medium/level 1 resource intensity: a registered nurse (RN) will provide monthly tailored behavioral support telephone calls + home BP monitoring. High/level 2 resource intensity: a pharmacist will provide monthly tailored behavioral support telephone calls + home BP monitoring + pharmacist-directed medication management. Booster (low) resource intensity: a licensed practical nurse (LPN) will provide non-tailored behavioral support telephone calls every two months to patients whose SBP comes under control. Booster/ low resource: A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months.
LPN Control
n=171 Participants
A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months (identical to booster (low) resource intensity component of the titrated intervention). The control arm will utilize the same procedures as the booster level for intervention patients for whom SBP comes under control. Booster/ low resource: A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months.
Number of Participants With Hypertension Control
66 Participants
63 Participants

SECONDARY outcome

Timeframe: 12 months

Population: 53 out of the 192 participants in the Titration Intervention group and 34 out of the 193 in the LPN control group had missing blood pressure measurement at 12 months due to not completing the assessment.

The investigators examined the difference in the degree of systolic BP control over the 18 months of the study between the intervention and control arms. Control was defined as SBP \< 130mmHg for hypertensive patients with diabetes and \< 140mmHg for patients without diabetes. Mean systolic blood pressure was calculated by the average of 3 blood pressure measurements collected at the 12-study visit.

Outcome measures

Outcome measures
Measure
Titration Intervention
n=139 Participants
The intervention arm includes three levels of resource intensity targeted to improve patients' systolic blood pressure (SBP) \[top number of blood pressure measurement\]. Medium/level 1 resource intensity: a registered nurse (RN) will provide monthly tailored behavioral support telephone calls + home BP monitoring. High/level 2 resource intensity: a pharmacist will provide monthly tailored behavioral support telephone calls + home BP monitoring + pharmacist-directed medication management. Booster (low) resource intensity: a licensed practical nurse (LPN) will provide non-tailored behavioral support telephone calls every two months to patients whose SBP comes under control. Booster/ low resource: A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months.
LPN Control
n=159 Participants
A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months (identical to booster (low) resource intensity component of the titrated intervention). The control arm will utilize the same procedures as the booster level for intervention patients for whom SBP comes under control. Booster/ low resource: A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months.
Number of Participants With Hypertension Control
58 Participants
67 Participants

SECONDARY outcome

Timeframe: 18 months

Population: 37 out of the 192 participants in the Titration Intervention group and 33 out of the 193 in the LPN control group had missing blood pressure measurement at 18 months due to not completing the assessment.

The investigators examined the difference in the degree of systolic BP control over the 18 months of the study between the intervention and control arms. Control was defined as SBP \< 130mmHg for hypertensive patients with diabetes and \< 140mmHg for patients without diabetes. Mean systolic blood pressure was calculated by the average of 3 blood pressure measurements collected at the18- month study visit.

Outcome measures

Outcome measures
Measure
Titration Intervention
n=155 Participants
The intervention arm includes three levels of resource intensity targeted to improve patients' systolic blood pressure (SBP) \[top number of blood pressure measurement\]. Medium/level 1 resource intensity: a registered nurse (RN) will provide monthly tailored behavioral support telephone calls + home BP monitoring. High/level 2 resource intensity: a pharmacist will provide monthly tailored behavioral support telephone calls + home BP monitoring + pharmacist-directed medication management. Booster (low) resource intensity: a licensed practical nurse (LPN) will provide non-tailored behavioral support telephone calls every two months to patients whose SBP comes under control. Booster/ low resource: A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months.
LPN Control
n=160 Participants
A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months (identical to booster (low) resource intensity component of the titrated intervention). The control arm will utilize the same procedures as the booster level for intervention patients for whom SBP comes under control. Booster/ low resource: A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months.
Number of Participants With Hypertension Control
84 Participants
69 Participants

SECONDARY outcome

Timeframe: Over 18 months of study intervention

Population: Intervention results did not show statistically significant differences between arms, therefore cost effectiveness analysis is not appropriate.

One of our secondary research questions was: "If the intervention results in greater reduction in SBP than the control group, is it cost effective?" Intervention results did not show statistically significant differences between arms, therefore cost effectiveness analysis was not appropriate. While cost effectiveness was not analyzed because it was a null trial, the investigators would have used resource utilization and cost data from VA data sets to measure VA outpatient and inpatient utilization and costs by arms over 18 months. The investigators would have examined hypertension-related outpatient pharmacy prescription counts and costs in order to compare them to total outpatient pharmacy costs and the investigators would have examined inpatient utilization and costs.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Baseline

Population: The numbers in the descriptive tables reflect #non-adherent.

The investigators assessed adherence using patient self-report on a modified Morisky scale using 4 items: * Do you ever forget to take your blood pressure medicine? * Are you careless at times about taking your blood pressure medicine? * When you feel better do you sometimes stop taking you blood pressure medicine? * Sometimes if you feel worse when you take your blood pressure medicine, do you stop taking it? The scale is a Yes(0) or No (1) answer. A response of YES to any one of the 4 items indicated non-adherence, and responses of all no indicated adherence. The numbers in the descriptive tables reflect number non-adherent.

Outcome measures

Outcome measures
Measure
Titration Intervention
n=192 Participants
The intervention arm includes three levels of resource intensity targeted to improve patients' systolic blood pressure (SBP) \[top number of blood pressure measurement\]. Medium/level 1 resource intensity: a registered nurse (RN) will provide monthly tailored behavioral support telephone calls + home BP monitoring. High/level 2 resource intensity: a pharmacist will provide monthly tailored behavioral support telephone calls + home BP monitoring + pharmacist-directed medication management. Booster (low) resource intensity: a licensed practical nurse (LPN) will provide non-tailored behavioral support telephone calls every two months to patients whose SBP comes under control. Booster/ low resource: A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months.
LPN Control
n=193 Participants
A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months (identical to booster (low) resource intensity component of the titrated intervention). The control arm will utilize the same procedures as the booster level for intervention patients for whom SBP comes under control. Booster/ low resource: A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months.
Number of Participants Who Did Not Achieve Medication Adherence
82 Participants
82 Participants

SECONDARY outcome

Timeframe: 6 months

Population: 30 out of the 192 participants in the Titration Intervention group and 21 out of the 193 in the LPN control group had missing medication adherence at 6 months due to not completing the assessment. The numbers in the descriptive tables reflect #non-adherent.

The investigators assessed adherence using patient self-report on a modified Morisky scale using 4 items: * Do you ever forget to take your blood pressure medicine? * Are you careless at times about taking your blood pressure medicine? * When you feel better do you sometimes stop taking you blood pressure medicine? * Sometimes if you feel worse when you take your blood pressure medicine, do you stop taking it? The scale is a Yes(0) or No (1) answer. A response of YES to any one of the 4 items indicated non-adherence, and responses of all no indicated adherence. The numbers in the descriptive tables reflect number non-adherent.

Outcome measures

Outcome measures
Measure
Titration Intervention
n=162 Participants
The intervention arm includes three levels of resource intensity targeted to improve patients' systolic blood pressure (SBP) \[top number of blood pressure measurement\]. Medium/level 1 resource intensity: a registered nurse (RN) will provide monthly tailored behavioral support telephone calls + home BP monitoring. High/level 2 resource intensity: a pharmacist will provide monthly tailored behavioral support telephone calls + home BP monitoring + pharmacist-directed medication management. Booster (low) resource intensity: a licensed practical nurse (LPN) will provide non-tailored behavioral support telephone calls every two months to patients whose SBP comes under control. Booster/ low resource: A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months.
LPN Control
n=172 Participants
A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months (identical to booster (low) resource intensity component of the titrated intervention). The control arm will utilize the same procedures as the booster level for intervention patients for whom SBP comes under control. Booster/ low resource: A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months.
Number of Participants Who Did Not Achieve Medication Adherence
62 Participants
69 Participants

SECONDARY outcome

Timeframe: 12 months

Population: 53 out of the 192 participants in the Titration Intervention group and 34 out of the 193 in the LPN control group had missing medication adherence at 12 months due to not completing the assessment. The numbers in the descriptive tables reflect #non-adherent.

The investigators assessed adherence using patient self-report on a modified Morisky scale using 4 items: * Do you ever forget to take your blood pressure medicine? * Are you careless at times about taking your blood pressure medicine? * When you feel better do you sometimes stop taking you blood pressure medicine? * Sometimes if you feel worse when you take your blood pressure medicine, do you stop taking it? The scale is a Yes(0) or No (1) answer. A response of YES to any one of the 4 items indicated non-adherence, and responses of all no indicated adherence. The numbers in the descriptive tables reflect number non-adherent.

Outcome measures

Outcome measures
Measure
Titration Intervention
n=139 Participants
The intervention arm includes three levels of resource intensity targeted to improve patients' systolic blood pressure (SBP) \[top number of blood pressure measurement\]. Medium/level 1 resource intensity: a registered nurse (RN) will provide monthly tailored behavioral support telephone calls + home BP monitoring. High/level 2 resource intensity: a pharmacist will provide monthly tailored behavioral support telephone calls + home BP monitoring + pharmacist-directed medication management. Booster (low) resource intensity: a licensed practical nurse (LPN) will provide non-tailored behavioral support telephone calls every two months to patients whose SBP comes under control. Booster/ low resource: A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months.
LPN Control
n=159 Participants
A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months (identical to booster (low) resource intensity component of the titrated intervention). The control arm will utilize the same procedures as the booster level for intervention patients for whom SBP comes under control. Booster/ low resource: A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months.
Number of Participants Who Did Not Achieve Medication Adherence
61 Participants
59 Participants

SECONDARY outcome

Timeframe: 18 months

Population: 37 out of the 192 participants in the Titration Intervention group and 33 out of the 193 in the LPN control group had missing medication adherence at 18 months due to not completing the assessment. The numbers in the descriptive tables reflect #non-adherent.

The investigators assessed adherence using patient self-report on a modified Morisky scale using 4 items: * Do you ever forget to take your blood pressure medicine? * Are you careless at times about taking your blood pressure medicine? * When you feel better do you sometimes stop taking you blood pressure medicine? * Sometimes if you feel worse when you take your blood pressure medicine, do you stop taking it? The scale is a Yes(0) or No (1) answer. A response of YES to any one of the 4 items indicated non-adherence, and responses of all no indicated adherence. The numbers in the descriptive tables reflect number non-adherent.

Outcome measures

Outcome measures
Measure
Titration Intervention
n=155 Participants
The intervention arm includes three levels of resource intensity targeted to improve patients' systolic blood pressure (SBP) \[top number of blood pressure measurement\]. Medium/level 1 resource intensity: a registered nurse (RN) will provide monthly tailored behavioral support telephone calls + home BP monitoring. High/level 2 resource intensity: a pharmacist will provide monthly tailored behavioral support telephone calls + home BP monitoring + pharmacist-directed medication management. Booster (low) resource intensity: a licensed practical nurse (LPN) will provide non-tailored behavioral support telephone calls every two months to patients whose SBP comes under control. Booster/ low resource: A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months.
LPN Control
n=160 Participants
A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months (identical to booster (low) resource intensity component of the titrated intervention). The control arm will utilize the same procedures as the booster level for intervention patients for whom SBP comes under control. Booster/ low resource: A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months.
Number of Participants Who Did Not Achieve Medication Adherence
73 Participants
68 Participants

Adverse Events

Titration Intervention

Serious events: 40 serious events
Other events: 117 other events
Deaths: 3 deaths

LPN Control

Serious events: 9 serious events
Other events: 112 other events
Deaths: 2 deaths

Serious adverse events

Serious adverse events
Measure
Titration Intervention
n=192 participants at risk
The intervention arm includes three levels of resource intensity targeted to improve patients' systolic blood pressure (SBP) \[top number of blood pressure measurement\]. Medium/level 1 resource intensity: a registered nurse (RN) will provide monthly tailored behavioral support telephone calls + home BP monitoring. High/level 2 resource intensity: a pharmacist will provide monthly tailored behavioral support telephone calls + home BP monitoring + pharmacist-directed medication management. Booster (low) resource intensity: a licensed practical nurse (LPN) will provide non-tailored behavioral support telephone calls every two months to patients whose SBP comes under control. Booster/ low resource: A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months.
LPN Control
n=193 participants at risk
A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months (identical to booster (low) resource intensity component of the titrated intervention). The control arm will utilize the same procedures as the booster level for intervention patients for whom SBP comes under control. Booster/ low resource: A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months.
Renal and urinary disorders
ER Visit
0.00%
0/192 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
0.52%
1/193 • Number of events 1 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
Infections and infestations
ER Visit
0.52%
1/192 • Number of events 1 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
0.52%
1/193 • Number of events 1 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
Cardiac disorders
ER Visit
1.6%
3/192 • Number of events 4 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
0.00%
0/193 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
Endocrine disorders
ER Visit
0.52%
1/192 • Number of events 1 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
0.00%
0/193 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
Cardiac disorders
Heart Attack
1.6%
3/192 • Number of events 4 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
0.00%
0/193 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
Cardiac disorders
Hospitalization Other
3.1%
6/192 • Number of events 7 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
1.6%
3/193 • Number of events 3 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
Blood and lymphatic system disorders
Hospitalization Other
0.00%
0/192 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
0.52%
1/193 • Number of events 1 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
Gastrointestinal disorders
Hospitalization Other
0.52%
1/192 • Number of events 1 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
0.52%
1/193 • Number of events 1 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
General disorders
Hospitalization Other
0.52%
1/192 • Number of events 1 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
0.00%
0/193 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
Infections and infestations
Hospitalization Other
0.52%
1/192 • Number of events 1 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
0.52%
1/193 • Number of events 1 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
Injury, poisoning and procedural complications
Hospitalization Other
1.0%
2/192 • Number of events 2 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
0.00%
0/193 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
Musculoskeletal and connective tissue disorders
Hospitalization Other
1.0%
2/192 • Number of events 2 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
0.00%
0/193 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Hospitalization Other
1.0%
2/192 • Number of events 2 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
0.00%
0/193 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
Renal and urinary disorders
Hospitalization Other
1.0%
2/192 • Number of events 3 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
0.00%
0/193 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
Respiratory, thoracic and mediastinal disorders
Hospitalization Other
1.0%
2/192 • Number of events 2 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
0.00%
0/193 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
Surgical and medical procedures
Hospitalization Other
3.6%
7/192 • Number of events 10 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
0.00%
0/193 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
Vascular disorders
Hospitalization Other
0.52%
1/192 • Number of events 1 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
0.00%
0/193 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
Cardiac disorders
Other
0.52%
1/192 • Number of events 1 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
0.52%
1/193 • Number of events 1 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Other
1.0%
2/192 • Number of events 2 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
0.00%
0/193 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
Hepatobiliary disorders
Other
0.52%
1/192 • Number of events 1 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
0.00%
0/193 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
Vascular disorders
Other
0.52%
1/192 • Number of events 1 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
0.00%
0/193 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.

Other adverse events

Other adverse events
Measure
Titration Intervention
n=192 participants at risk
The intervention arm includes three levels of resource intensity targeted to improve patients' systolic blood pressure (SBP) \[top number of blood pressure measurement\]. Medium/level 1 resource intensity: a registered nurse (RN) will provide monthly tailored behavioral support telephone calls + home BP monitoring. High/level 2 resource intensity: a pharmacist will provide monthly tailored behavioral support telephone calls + home BP monitoring + pharmacist-directed medication management. Booster (low) resource intensity: a licensed practical nurse (LPN) will provide non-tailored behavioral support telephone calls every two months to patients whose SBP comes under control. Booster/ low resource: A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months.
LPN Control
n=193 participants at risk
A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months (identical to booster (low) resource intensity component of the titrated intervention). The control arm will utilize the same procedures as the booster level for intervention patients for whom SBP comes under control. Booster/ low resource: A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months.
Cardiac disorders
ER Visit
6.8%
13/192 • Number of events 15 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
7.8%
15/193 • Number of events 25 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
Gastrointestinal disorders
ER Visit
4.7%
9/192 • Number of events 9 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
3.1%
6/193 • Number of events 7 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
General disorders
ER Visit
10.4%
20/192 • Number of events 24 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
11.4%
22/193 • Number of events 31 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
Infections and infestations
ER Visit
8.9%
17/192 • Number of events 20 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
10.9%
21/193 • Number of events 31 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
Injury, poisoning and procedural complications
ER Visit
6.8%
13/192 • Number of events 14 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
1.0%
2/193 • Number of events 2 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
Musculoskeletal and connective tissue disorders
ER Visit
10.4%
20/192 • Number of events 31 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
13.5%
26/193 • Number of events 39 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
Respiratory, thoracic and mediastinal disorders
ER Visit
2.1%
4/192 • Number of events 4 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
4.7%
9/193 • Number of events 12 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
Cardiac disorders
Hospitalization Other
5.7%
11/192 • Number of events 11 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
5.7%
11/193 • Number of events 19 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
Surgical and medical procedures
Hospitalization Other
5.7%
11/192 • Number of events 12 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.
5.7%
11/193 • Number of events 13 • 18 months
It is expected that these patients will have a variety of episodes related to cardiovascular and related diseases such as diabetes, age, smoking and drinking. These may include, but are not limited to, heart attack, stroke, and complications of diabetes among those patients with the disease, the diagnosis of cancer and dementia, development of disease of the lung or liver.

Additional Information

Dr. George Lee Jackson, PhD MHA

Durham VA Medical Center, Durham, NC

Phone: 919-286-0411

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place